GlassScriptPhysician profile
Piya Ghoshal
NPI 1417164799
$4,316.43
in general payments reported to CMS, 2019-2025
28 companies · $550 in 2025
The $550 reported for 2025 was more than what 75% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $497 · 2021: $645 · 2022: $602 · 2023: $650 · 2024: $572 · 2025: $550.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,765 · Education: $7.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,765.35 |
| Education | $7.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $738.74 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $414.54 | 2019-2024 | Trelegy Ellipta |
| Amgen INC. | $405.95 | 2019-2025 | Repatha, Otezla, Repatha |
| Currax Pharmaceuticals LLC | $396.69 | 2020-2025 | Contrave |
| Vivus LLC | $383.49 | 2019-2025 | Qsymia |
| Novo Nordisk INC | $321.93 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Amarin Pharma, INC. | $309.21 | 2019-2022 | |
| Lilly USA, LLC | $304.43 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Pfizer INC. | $182.53 | 2020-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $148.88 | 2019-2024 | Ofev |
| Eisai INC. | $100.91 | 2019-2021 | |
| Exact Sciences Corporation | $94.91 | 2023-2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $79.38 | 2019-2021 | |
| Abbvie INC. | $65.62 | 2022-2023 | |
| Intra-Sana Laboratories | $57.16 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $53.37 | 2024 | Inspire |
| Janssen Pharmaceuticals, INC | $33.02 | 2019-2021 | |
| Dexcom, INC. | $30.78 | 2022-2023 | Dexcom G6 Transmitter |
| Sanofi-Aventis U.S. LLC | $30.22 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $28.99 | 2020-2021 | |
| Renalytix Ai, INC. | $19.66 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Abbott Laboratories | $18.65 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.02 | 2024 | Zoryve |
| Bayer Healthcare Pharmaceuticals INC. | $17.99 | 2023 | |
| Bausch Health US, LLC | $17.20 | 2025 | Aplenzin |
| Nalpropion Pharmaceuticals LLC | $16.16 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.56 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Piya Ghoshal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.